<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Goonawardane N</submitter><funding>Wellcome Trust</funding><pagination>e0081822</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9517736</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>96(18)</volume><pubmed_abstract>Tick-borne encephalitis virus (TBEV) is an important human arthropod-borne virus that causes tick-borne encephalitis (TBE) in humans. TBEV acutely infects the central nervous system (CNS), leading to neurological symptoms of various severity. No therapeutics are currently available for TBEV-associated disease. Virus strains of various pathogenicity have been described, although the basis of their diverse clinical outcome remains undefined. Work with infectious TBEV requires high-level biocontainment, meaning model systems that can recapitulate the virus life cycle are highly sought. Here, we report the generation of a self-replicating, noninfectious TBEV replicon used to study properties of high (Hypr) and low (Vs) pathogenic TBEV isolates. Using a Spinach2 RNA aptamer and luciferase repor</pubmed_abstract><journal>Journal of virology</journal><pubmed_title>Identification of Host Factors Differentially Induced by Clinically Diverse Strains of Tick-Borne Encephalitis Virus.</pubmed_title><pmcid>PMC9517736</pmcid><funding_grant_id>096670/Z/11/Z</funding_grant_id><funding_grant_id>104918/Z/14/Z</funding_grant_id><pubmed_authors>Harris M</pubmed_authors><pubmed_authors>Goonawardane N</pubmed_authors><pubmed_authors>Upstone L</pubmed_authors><pubmed_authors>Jones IM</pubmed_authors></additional><is_claimable>false</is_claimable><name>Identification of Host Factors Differentially Induced by Clinically Diverse Strains of Tick-Borne Encephalitis Virus.</name><description>Tick-borne encephalitis virus (TBEV) is an important human arthropod-borne virus that causes tick-borne encephalitis (TBE) in humans. TBEV acutely infects the central nervous system (CNS), leading to neurological symptoms of various severity. No therapeutics are currently available for TBEV-associated disease. Virus strains of various pathogenicity have been described, although the basis of their diverse clinical outcome remains undefined. Work with infectious TBEV requires high-level biocontainment, meaning model systems that can recapitulate the virus life cycle are highly sought. Here, we report the generation of a self-replicating, noninfectious TBEV replicon used to study properties of high (Hypr) and low (Vs) pathogenic TBEV isolates. Using a Spinach2 RNA aptamer and luciferase repor</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Sep</publication><modification>2025-04-04T19:40:41.312Z</modification><creation>2024-11-07T11:59:36.173Z</creation></dates><accession>S-EPMC9517736</accession><cross_references><pubmed>36098513</pubmed><doi>10.1128/jvi.00818-22</doi></cross_references></HashMap>